T cells

Autolomous and Vineti form strategic partnership to deliver end to end supply chain management solutions for cell and gene therapy sector

Autolomous LTD, the market leading developer of critical manufacturing management systems for cell and gene therapies, and Vineti, a provider of leading digital enterprise platforms for cell and gene therapy supply chains, today announce a non-exclusive collaborative partnership.

Read More
January 15, 2020

Vineti Announces New Board of Directors Member

SAN FRANCISCO, January 15, 2020 — Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics,...

December 30, 2019

Advanced therapy supply chains: lessons from 100 meetings

You can learn a lot in 100 meetings. In 2019, I conducted more than 100 discussions on advanced therapy supply...

December 17, 2019

WoVen, a podcast from Canaan featuring Amy DuRoss

One of Vineti’s board members, Nina Kjellson, General Partner, at Canaan started a podcast called WoVen, about women who venture. We’re excited to...

November 26, 2019

Design for Healthcare IRL at Vineti, a Meetup

More and more of today’s healthcare happens online and digital is just one part of the picture. Much of the...

September 19, 2019

The road ahead for #regenmed

This fall, it will be 15 years since regenerative medicine faced a crisis of funding and support in the United...

August 22, 2019

September events! A Big Data webinar with Dr. Scott Burger, and a talk at CAR-TCR Summit

September marks the start of the autumn conference season in cell and gene therapy, and this fall I’m looking forward to...

August 13, 2019

Patient experiences – three inspiring stories

Every person working in cell therapies and gene therapies does so for the potential to improve patients’ lives. Emily Whitehead,...

August 8, 2019

Cell therapy and gene therapy news: updates from some of our biopharmaceutical partners

We’re always excited to support the innovation pursued by our biopharmaceutical partners as they work toward improved patient outcomes. Here...

July 22, 2019

Cell therapy and gene therapy — three summer reads that “get it”

In cell therapy, gene therapy, and personalized cancer vaccines, most media coverage understandably focuses on the medicine — the amazing...

July 1, 2019

Vineti selected as Technology Pioneer by the World Economic Forum

Each year, the World Economic Forum welcomes leading early-stage companies from around the world into its Technology Pioneers community. Today, I’m both thrilled and...

June 26, 2019

Vineti joins the leadership of the Standards Coordinating Body

At Vineti, we’re pushing every day to help the field of advanced therapies — cell therapy, gene therapy, personalized cancer...

May 22, 2019

Cell and gene therapy standards need you!

One week to go! In the next seven days, those of us working in cell and gene therapy have a...